These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15015724)

  • 1. EI-2346, a novel interleukin-1beta converting enzyme inhibitor produced by Streptomyces sp. E-2346. I. Taxonomy of producing strain, fermentation, isolation, physico-chemical properties, and biological properties.
    Koizumi F; Hasegawa A; Ochiai K; Ando K; Kondo H; Yoshida M; Matsuda Y; Nakanishi S
    J Antibiot (Tokyo); 2003 Dec; 56(12):985-92. PubMed ID: 15015724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EI-2128-1, a novel interleukin-1beta converting enzyme inhibitor produced by Penicillium sp. E-2128.
    Koizumi F; Agatsuma T; Ando K; Kondo H; Saitoh Y; Matsuda Y; Nakanishi S
    J Antibiot (Tokyo); 2003 Nov; 56(11):891-8. PubMed ID: 14763553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EI-1511-3, -5 and EI-1625-2, novel interleukin-1 beta converting enzyme inhibitors produced by Streptomyces sp. E-1511 and E-1625. I. Taxonomy of producing strain, fermentation and isolation.
    Tanaka T; Tsukuda E; Ochiai K; Kondo H; Teshiba S; Matsuda Y
    J Antibiot (Tokyo); 1996 Nov; 49(11):1073-8. PubMed ID: 8982333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EI-1511-3, -5 and EI-1625-2, novel interleukin-1 beta converting enzyme inhibitors produced by Streptomyces sp. E-1511 and E-1625. III. Biochemical properties of EI-1511-3, -5 and EI-1625-2.
    Tanaka T; Tsukuda E; Uosaki Y; Matsuda Y
    J Antibiot (Tokyo); 1996 Nov; 49(11):1085-90. PubMed ID: 8982335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EI-1941-1 and -2, novel interleukin-1 beta converting enzyme inhibitors Produced by Farrowia sp. E-1941. II. Taxonomy of producing strain, fermentation, isolation, physico-chemical properties, and biological properties.
    Koizumi F; Ishiguro H; Ando K; Kondo H; Yoshida M; Matsuda Y; Nakanishi S
    J Antibiot (Tokyo); 2003 Jul; 56(7):603-9. PubMed ID: 14513902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EI-2346, a novel interleukin-1beta converting enzyme inhibitor produced by Streptomyces sp. E-2346. II. Structure elucidation.
    Koizumi F; Hasegawa A; Yoshida M; Matsuda Y; Nakanishi S
    J Antibiot (Tokyo); 2004 Apr; 57(4):289-90. PubMed ID: 15217194
    [No Abstract]   [Full Text] [Related]  

  • 7. EI-1507-1 and -2, novel interleukin-1 beta converting enzyme inhibitors produced by Streptomyces sp. E-1507.
    Tsukuda E; Tanaka T; Ochiai K; Kondo H; Yoshida M; Agatsuma T; Saitoh Y; Teshiba S; Matsuda Y
    J Antibiot (Tokyo); 1996 Apr; 49(4):333-9. PubMed ID: 8641994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EI-1941-1 and -2, novel interleukin-1beta converting enzyme inhibitors produced by Farrowia sp. E-1941. I. Biochemical characterization of EI-1941-1 and -2.
    Koizumi F; Matsuda Y; Nakanishi S
    J Antibiot (Tokyo); 2003 May; 56(5):464-9. PubMed ID: 12870812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMC-66, a new endothelin converting enzyme inhibitor produced by Streptomyces sp. A5008.
    Asai Y; Nonaka N; Suzuki S; Nishio M; Takahashi K; Shima H; Ohmori K; Ohnuki T; Komatsubara S
    J Antibiot (Tokyo); 1999 Jul; 52(7):607-12. PubMed ID: 10513839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RES-701-2, -3 and -4, novel and selective endothelin type B receptor antagonists produced by Streptomyces sp. I. Taxonomy of producing strains, fermentation, isolation, and biochemical properties.
    Ogawa T; Ochiai K; Tanaka T; Tsukuda E; Chiba S; Yano K; Yamasaki M; Yoshida M; Matsuda Y
    J Antibiot (Tokyo); 1995 Nov; 48(11):1213-20. PubMed ID: 8557559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JBIR-76 and JBIR-77, modified naphthoquinones from Streptomyces sp. RI-77.
    Motohashi K; Izumikawa M; Kagaya N; Takagi M; Shin-Ya K
    J Antibiot (Tokyo); 2016 Sep; 69(9):707-8. PubMed ID: 26732254
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphatoquinones A and B, novel tyrosine phosphatase inhibitors produced by Streptomyces sp.
    Kagamizono T; Hamaguchi T; Ando T; Sugawara K; Adachi T; Osada H
    J Antibiot (Tokyo); 1999 Feb; 52(2):75-80. PubMed ID: 10344559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RES-701-1, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. I. Characterization of producing strain, fermentation, isolation, physico-chemical and biological properties.
    Morishita Y; Chiba S; Tsukuda E; Tanaka T; Ogawa T; Yamasaki M; Yoshida M; Kawamoto I; Matsuda Y
    J Antibiot (Tokyo); 1994 Mar; 47(3):269-75. PubMed ID: 8175478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel alpha-glucosidase inhibitors, CKD-711 and CKD-711a produced by Streptomyces sp. CK-4416. I. Taxonomy, fermentation and isolation.
    Kim JG; Chang HB; Kwon YI; Moon SK; Chun HS; Ahn SK; Hong CI
    J Antibiot (Tokyo); 2002 May; 55(5):457-61. PubMed ID: 12139013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluostatins A and B, new inhibitors of dipeptidyl peptidase III, produced by Streptomyces sp. TA-3391. I. Taxonomy of producing strain, production, isolation, physico-chemical properties and biological properties.
    Akiyama T; Harada S; Kojima F; Takahashi Y; Imada C; Okami Y; Muraoka Y; Aoyagi T; Takeuchi T
    J Antibiot (Tokyo); 1998 Jun; 51(6):553-9. PubMed ID: 9711218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PS-5, a new beta-lactam antibiotic. I. Taxonomy of the producing organism, isolation and physico-chemical properties.
    Okamura K; Hirata S; Koki A; Hori K; Shibamoto N; Okumura Y; Okabe M; Okamoto R; Kouno K; Fukagawa Y; Shimauchi Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1979 Apr; 32(4):262-71. PubMed ID: 468714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epostatin, new inhibitor of dipeptidyl peptidase II, produced by Streptomyces sp. MJ995-OF5. I. Taxonomy of producing strain, fermentation, isolation, physico-chemical properties and biological properties.
    Akiyama T; Harada S; Kojima F; Kinoshita N; Hamada M; Muraoka Y; Aoyagi T; Takeuchi T
    J Antibiot (Tokyo); 1998 Mar; 51(3):253-60. PubMed ID: 9589059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI-200 and PI-201, new platelet aggregation inhibitors produced by Streptomyces sp. A7498. Taxonomy, fermentation, isolation, physico-chemical properties, structure determination and biological properties.
    Kishimura Y; Kawashima A; Kagamizono T; Yamagishi M; Matsumoto K; Kawashima Y; Hanada K
    J Antibiot (Tokyo); 1992 Jun; 45(6):892-8. PubMed ID: 1500356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphostin (LK6-A), a novel immunosuppressant from Streptomyces sp. KY11783: taxonomy of the producing organism, fermentation, isolation and biological activities.
    Nagata H; Ochiai K; Aotani Y; Ando K; Yoshida M; Takahashi I; Tamaoki T
    J Antibiot (Tokyo); 1997 Jul; 50(7):537-42. PubMed ID: 9711243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A-72363 A-1, A-2 and C, novel heparanase inhibitors from Streptomyces nobilis SANK 60192. I. Taxonomy of producing organism, fermentation, isolation and structure elucidation.
    Takatsu T; Takahashi M; Kawase Y; Enokita R; Okazaki T; Matsukawa H; Ogawa K; Sakaida Y; Kagasaki T; Kinoshita T; Nakajima M; Tanzawa K
    J Antibiot (Tokyo); 1996 Jan; 49(1):54-60. PubMed ID: 8609086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.